Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF).

MODY2 is the most prevalent monogenic form of diabetes in Italy with an estimated prevalence of about 0.5-1.5%. MODY2 is potentially indistinguishable from other forms of diabetes, however, its identification impacts on patients' quality of life and healthcare resources. Unfortunately, DNA dire...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michele Pinelli, Fabio Acquaviva, Fabrizio Barbetti, Elisabetta Caredda, Sergio Cocozza, Maurizio Delvecchio, Enza Mozzillo, Daniele Pirozzi, Francesco Prisco, Ivana Rabbone, Lucia Sacchetti, Nadia Tinto, Sonia Toni, Stefano Zucchini, Dario Iafusco, Italian Study Group on Diabetes of the Italian Society of Pediatric Endocrinology and Diabetology
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/02721dbc280447c7b089b29536fb6e48
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:02721dbc280447c7b089b29536fb6e48
record_format dspace
spelling oai:doaj.org-article:02721dbc280447c7b089b29536fb6e482021-11-18T08:47:22ZIdentification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF).1932-620310.1371/journal.pone.0079933https://doaj.org/article/02721dbc280447c7b089b29536fb6e482013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24244580/?tool=EBIhttps://doaj.org/toc/1932-6203MODY2 is the most prevalent monogenic form of diabetes in Italy with an estimated prevalence of about 0.5-1.5%. MODY2 is potentially indistinguishable from other forms of diabetes, however, its identification impacts on patients' quality of life and healthcare resources. Unfortunately, DNA direct sequencing as diagnostic test is not readily accessible and expensive. In addition current guidelines, aiming to establish when the test should be performed, proved a poor detection rate. Aim of this study is to propose a reliable and easy-to-use tool to identify candidate patients for MODY2 genetic testing. We designed and validated a diagnostic flowchart in the attempt to improve the detection rate and to increase the number of properly requested tests. The flowchart, called 7-iF, consists of 7 binary "yes or no" questions and its unequivocal output is an indication for whether testing or not. We tested the 7-iF to estimate its clinical utility in comparison to the clinical suspicion alone. The 7-iF, in a prospective 2-year study (921 diabetic children) showed a precision of about the 76%. Using retrospective data, the 7-iF showed a precision in identifying MODY2 patients of about 80% compared to the 40% of the clinical suspicion. On the other hand, despite a relatively high number of missing MODY2 patients, the 7-iF would not suggest the test for 90% of the non-MODY2 patients, demonstrating that a wide application of this method might 1) help less experienced clinicians in suspecting MODY2 patients and 2) reducing the number of unnecessary tests. With the 7-iF, a clinician can feel confident of identifying a potential case of MODY2 and suggest the molecular test without fear of wasting time and money. A Qaly-type analysis estimated an increase in the patients' quality of life and savings for the health care system of about 9 million euros per year.Michele PinelliFabio AcquavivaFabrizio BarbettiElisabetta CareddaSergio CocozzaMaurizio DelvecchioEnza MozzilloDaniele PirozziFrancesco PriscoIvana RabboneLucia SacchettiNadia TintoSonia ToniStefano ZucchiniDario IafuscoItalian Study Group on Diabetes of the Italian Society of Pediatric Endocrinology and DiabetologyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e79933 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Michele Pinelli
Fabio Acquaviva
Fabrizio Barbetti
Elisabetta Caredda
Sergio Cocozza
Maurizio Delvecchio
Enza Mozzillo
Daniele Pirozzi
Francesco Prisco
Ivana Rabbone
Lucia Sacchetti
Nadia Tinto
Sonia Toni
Stefano Zucchini
Dario Iafusco
Italian Study Group on Diabetes of the Italian Society of Pediatric Endocrinology and Diabetology
Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF).
description MODY2 is the most prevalent monogenic form of diabetes in Italy with an estimated prevalence of about 0.5-1.5%. MODY2 is potentially indistinguishable from other forms of diabetes, however, its identification impacts on patients' quality of life and healthcare resources. Unfortunately, DNA direct sequencing as diagnostic test is not readily accessible and expensive. In addition current guidelines, aiming to establish when the test should be performed, proved a poor detection rate. Aim of this study is to propose a reliable and easy-to-use tool to identify candidate patients for MODY2 genetic testing. We designed and validated a diagnostic flowchart in the attempt to improve the detection rate and to increase the number of properly requested tests. The flowchart, called 7-iF, consists of 7 binary "yes or no" questions and its unequivocal output is an indication for whether testing or not. We tested the 7-iF to estimate its clinical utility in comparison to the clinical suspicion alone. The 7-iF, in a prospective 2-year study (921 diabetic children) showed a precision of about the 76%. Using retrospective data, the 7-iF showed a precision in identifying MODY2 patients of about 80% compared to the 40% of the clinical suspicion. On the other hand, despite a relatively high number of missing MODY2 patients, the 7-iF would not suggest the test for 90% of the non-MODY2 patients, demonstrating that a wide application of this method might 1) help less experienced clinicians in suspecting MODY2 patients and 2) reducing the number of unnecessary tests. With the 7-iF, a clinician can feel confident of identifying a potential case of MODY2 and suggest the molecular test without fear of wasting time and money. A Qaly-type analysis estimated an increase in the patients' quality of life and savings for the health care system of about 9 million euros per year.
format article
author Michele Pinelli
Fabio Acquaviva
Fabrizio Barbetti
Elisabetta Caredda
Sergio Cocozza
Maurizio Delvecchio
Enza Mozzillo
Daniele Pirozzi
Francesco Prisco
Ivana Rabbone
Lucia Sacchetti
Nadia Tinto
Sonia Toni
Stefano Zucchini
Dario Iafusco
Italian Study Group on Diabetes of the Italian Society of Pediatric Endocrinology and Diabetology
author_facet Michele Pinelli
Fabio Acquaviva
Fabrizio Barbetti
Elisabetta Caredda
Sergio Cocozza
Maurizio Delvecchio
Enza Mozzillo
Daniele Pirozzi
Francesco Prisco
Ivana Rabbone
Lucia Sacchetti
Nadia Tinto
Sonia Toni
Stefano Zucchini
Dario Iafusco
Italian Study Group on Diabetes of the Italian Society of Pediatric Endocrinology and Diabetology
author_sort Michele Pinelli
title Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF).
title_short Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF).
title_full Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF).
title_fullStr Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF).
title_full_unstemmed Identification of candidate children for maturity-onset diabetes of the young type 2 (MODY2) gene testing: a seven-item clinical flowchart (7-iF).
title_sort identification of candidate children for maturity-onset diabetes of the young type 2 (mody2) gene testing: a seven-item clinical flowchart (7-if).
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/02721dbc280447c7b089b29536fb6e48
work_keys_str_mv AT michelepinelli identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT fabioacquaviva identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT fabriziobarbetti identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT elisabettacaredda identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT sergiococozza identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT mauriziodelvecchio identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT enzamozzillo identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT danielepirozzi identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT francescoprisco identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT ivanarabbone identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT luciasacchetti identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT nadiatinto identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT soniatoni identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT stefanozucchini identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT darioiafusco identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
AT italianstudygroupondiabetesoftheitaliansocietyofpediatricendocrinologyanddiabetology identificationofcandidatechildrenformaturityonsetdiabetesoftheyoungtype2mody2genetestingasevenitemclinicalflowchart7if
_version_ 1718421303374905344